Cargando…
Generating in vitro models of NTRK-fusion mesenchymal neoplasia as tools for investigating kinase oncogenic activation and response to targeted therapy
The discovery of neurotrophic tyrosine receptor kinase (NTRK) gene fusions as pan-tumor oncogenic drivers has led to new personalized therapies in oncology. Recent studies investigating NTRK fusions among mesenchymal neoplasms have identified several emerging soft tissue tumor entities displaying va...
Autores principales: | Vanoli, Fabio, Herviou, Laurie, Tsuda, Yusuke, Sung, Patricia, Xie, Ziyu, Fishinevich, Eve, Min, Soe S., Mallen, William, de Wardin, Henry de Traux, Zhang, Yanming, Jasin, Maria, Antonescu, Cristina R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938185/ https://www.ncbi.nlm.nih.gov/pubmed/36801905 http://dx.doi.org/10.1038/s41389-023-00454-6 |
Ejemplares similares
-
Generation of human embryonic stem cell models to exploit the EWSR1-CREB fusion promiscuity as a common pathway of transformation in human tumors
por: Vanoli, Fabio, et al.
Publicado: (2021) -
Genomic Evolution and Personalized Therapy of an Infantile Fibrosarcoma Harboring an NTRK Oncogenic Fusion
por: Thorwarth, Anne, et al.
Publicado: (2022) -
Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse
por: de Traux de Wardin, Henry, et al.
Publicado: (2023) -
Dermoscopic Features of Spitz Tumor With LMNA-NTRK1 Fusion
por: Friedman, Ben J., et al.
Publicado: (2020) -
The Impact of ETV6-NTRK3 Oncogenic Gene Fusions on Molecular and Signaling Pathway Alterations
por: Kinnunen, Matias, et al.
Publicado: (2023)